600771.SS SHH
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
1W: +0.7%
1M: +2.5%
3M: +1.9%
YTD: -22.1%
1Y: -32.8%
3Y: -56.1%
5Y: -32.2%
¥14.15 ($2.11)
+0.26 (+1.87%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$112M
-47.8% ▼
Capital Expenditures
$9M
-249.6% ▼
5Y CAGR: -36.8%
Free Cash Flow
$104M
-51.4% ▼
Dividends Paid
$4M
+72.4% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$142M
-1188.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $32M | -$332M | -$364M | $93M | $84M |
| Depreciation & Amort. | $38M | $38M | $42M | $46M | $54M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$219M | $370M | $541M | $38M | -$106M |
| Other Non-Cash Items | $90M | $6M | $47M | $39M | $81M |
| Operating Cash Flow | -$76M | $81M | $253M | $215M | $112M |
| — Investing Activities — | |||||
| Capital Expenditures | -$50M | -$18M | -$9M | -$3M | -$9M |
| Acquisitions (Net) | $51M | $513 | $33K | $0 | $0 |
| Investment Purchases | -$17M | -$2M | -$33K | $0 | $0 |
| Investment Sales | $7M | $2M | $1M | $352K | $2M |
| Other Investing | -$50M | $0 | $33K | $974K | $43K |
| Investing Cash Flow | -$59M | -$18M | -$7M | -$1M | -$7M |
| — Financing Activities — | |||||
| Net Debt Issuance | $162M | -$8M | $97M | -$179M | -$246M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$11M | -$18M | -$20M | -$14M | -$4M |
| Other Financing | -$31M | -$82M | -$180M | -$8M | $3M |
| Financing Cash Flow | $121M | -$108M | -$103M | -$201M | -$247M |
| Net Change in Cash | -$13M | -$44M | $143M | $13M | -$142M |
| Cash End of Period | $145M | $101M | $244M | $257M | $115M |
| Free Cash Flow | -$125M | $63M | $245M | $213M | $104M |